159 related articles for article (PubMed ID: 10432007)
1. CD44s-targeted treatment with monoclonal antibody blocks intracerebral invasion and growth of 9L gliosarcoma.
Gunia S; Hussein S; Radu DL; Pütz KM; Breyer R; Hecker H; Samii M; Walter GF; Stan AC
Clin Exp Metastasis; 1999 May; 17(3):221-30. PubMed ID: 10432007
[TBL] [Abstract][Full Text] [Related]
2. Disruption of intracerebral progression of C6 rat glioblastoma by in vivo treatment with anti-CD44 monoclonal antibody.
Breyer R; Hussein S; Radu DL; Pütz KM; Gunia S; Hecker H; Samii M; Walter GF; Stan AC
J Neurosurg; 2000 Jan; 92(1):140-9. PubMed ID: 10616093
[TBL] [Abstract][Full Text] [Related]
3. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
Wang X; Duan X; Yang G; Zhang X; Deng L; Zheng H; Deng C; Wen J; Wang N; Peng C; Zhao X; Wei Y; Chen L
PLoS One; 2011 Apr; 6(4):e18490. PubMed ID: 21559510
[TBL] [Abstract][Full Text] [Related]
4. CD44 plays a role in adhesive interactions between glioma cells and extracellular matrix components.
Radotra B; McCormick D; Crockard A
Neuropathol Appl Neurobiol; 1994 Aug; 20(4):399-405. PubMed ID: 7528901
[TBL] [Abstract][Full Text] [Related]
5. Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.
Giezeman-Smits KM; Okada H; Brissette-Storkus CS; Villa LA; Attanucci J; Lotze MT; Pollack IF; Bozik ME; Chambers WH
Cancer Res; 2000 May; 60(9):2449-57. PubMed ID: 10811123
[TBL] [Abstract][Full Text] [Related]
6. Blockade of metastasis formation by CD44-receptor globulin.
Zawadzki V; Perschl A; Rösel M; Hekele A; Zöller M
Int J Cancer; 1998 Mar; 75(6):919-24. PubMed ID: 9506538
[TBL] [Abstract][Full Text] [Related]
7. Characterization of gastrin-induced cytostatic effect on cell proliferation in experimental malignant gliomas.
Lefranc F; Sadeghi N; Metens T; Brotchi J; Salmon I; Kiss R
Neurosurgery; 2003 Apr; 52(4):881-90; discussion 890-1. PubMed ID: 12657185
[TBL] [Abstract][Full Text] [Related]
8. Invasive phenotype observed in 1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat glioma cells: a tumor model mimicking a recurrent malignant glioma.
Saito R; Bringas J; Mirek H; Berger MS; Bankiewicz KS
J Neurosurg; 2004 Nov; 101(5):826-31. PubMed ID: 15540922
[TBL] [Abstract][Full Text] [Related]
9. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.
Yang T; Witham TF; Villa L; Erff M; Attanucci J; Watkins S; Kondziolka D; Okada H; Pollack IF; Chambers WH
Cancer Res; 2002 May; 62(9):2583-91. PubMed ID: 11980653
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronate receptors mediating glioma cell migration and proliferation.
Akiyama Y; Jung S; Salhia B; Lee S; Hubbard S; Taylor M; Mainprize T; Akaishi K; van Furth W; Rutka JT
J Neurooncol; 2001 Jun; 53(2):115-27. PubMed ID: 11716065
[TBL] [Abstract][Full Text] [Related]
11. Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.
Okada H; Attanucci J; Giezeman-Smits KM; Brissette-Storkus C; Fellows WK; Gambotto A; Pollack LF; Pogue-Geile K; Lotze MT; Bozik ME; Chambers WH
Cancer Res; 2001 Mar; 61(6):2625-31. PubMed ID: 11289140
[TBL] [Abstract][Full Text] [Related]
12. Expression of a soluble transforming growth factor-beta (TGFbeta) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo.
Witham TF; Villa L; Yang T; Pollack IF; Okada H; Robbins PD; Chambers WH
J Neurooncol; 2003; 64(1-2):63-9. PubMed ID: 12952287
[TBL] [Abstract][Full Text] [Related]
13. A rat glioma model, CNS-1, with invasive characteristics similar to those of human gliomas: a comparison to 9L gliosarcoma.
Kruse CA; Molleston MC; Parks EP; Schiltz PM; Kleinschmidt-DeMasters BK; Hickey WF
J Neurooncol; 1994; 22(3):191-200. PubMed ID: 7760095
[TBL] [Abstract][Full Text] [Related]
14. Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion.
Afify A; Purnell P; Nguyen L
Exp Mol Pathol; 2009 Apr; 86(2):95-100. PubMed ID: 19167378
[TBL] [Abstract][Full Text] [Related]
15. Expression of a cleaved brain-specific extracellular matrix protein mediates glioma cell invasion In vivo.
Zhang H; Kelly G; Zerillo C; Jaworski DM; Hockfield S
J Neurosci; 1998 Apr; 18(7):2370-6. PubMed ID: 9502798
[TBL] [Abstract][Full Text] [Related]
16. Stable alterations of CD44 isoform expression in prostate cancer cells decrease invasion and growth and alter ligand binding and chemosensitivity.
Yang K; Tang Y; Habermehl GK; Iczkowski KA
BMC Cancer; 2010 Jan; 10():16. PubMed ID: 20074368
[TBL] [Abstract][Full Text] [Related]
17. Down-modulation of host reactivity by anti-CD44 in skin transplantation.
Seiter S; Weber B; Tilgen W; Zöller M
Transplantation; 1998 Sep; 66(6):778-91. PubMed ID: 9771842
[TBL] [Abstract][Full Text] [Related]
18. Role of estrogen receptor-related antigen in initiating the growth of human glioma cells.
Khalid MH; Shibata S; Furukawa K; Nadel A; Ammerman MD; Caputy AJ
J Neurosurg; 2004 May; 100(5):923-30. PubMed ID: 15137610
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy.
Chen L; Waxman DJ
Cancer Res; 1995 Feb; 55(3):581-9. PubMed ID: 7834628
[TBL] [Abstract][Full Text] [Related]
20. CD44 expression in human gliomas.
Ranuncolo SM; Ladeda V; Specterman S; Varela M; Lastiri J; Morandi A; Matos E; Bal de Kier Joffé E; Puricelli L; Pallotta MG
J Surg Oncol; 2002 Jan; 79(1):30-5; discussion 35-6. PubMed ID: 11754374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
